Source: Annual Congress 2005 - Thoracic imaging: clinical applications
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Habesoglu, N. Kacar, M. Karatasli, F. Tercan, D. Kilic (Adana, Turkey). Case report: aberrant systemic arterial supply anomalous of normal lung. Eur Respir J 2005; 26: Suppl. 49, 2087

Member's Comments

No comment yet.

Related content which might interest you: ‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Case report: Misunderstanding the arterial blood oxygen saturation Source: Breathe 2013; 9: 225-230 Year: 2013 Metastatic pulmonary leiomyosarcom: case report Source: Eur Respir J 2006; 28: Suppl. 50, 90s Year: 2006 Case 1: Is it lung parenchyma-associated pulmonary hypertension or PAH? Source: International Congress 2017 – CC6 Is it truly pulmonary arterial hypertension? Year: 2017 Primary cardiac angiosarcoma and diffuse pulmonary hemorrhage: case report Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Pulmonary arterial hypertension (PAH) in primary Sjögren‘s syndrome: report of 9 cases Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Pulmonary hypertension and pulmonary vascular disease: course report Source: Breathe, 14 (1) e4; 10.1183/20734735.019917 Year: 2018 Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Correspondence regarding “T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease”: a single-centre case series Source: Eur Respir J, 55 (5) 1902272; 10.1183/13993003.02272-2019 Year: 2020 Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update Source: Eur Respir J, 53 (1) 1801900; 10.1183/13993003.01900-2018 Year: 2019 Morphological and molecular alterations of pulmonary vasculature in a pig model with increased pulmonary blood flow and pressure compared to "pulmonary plexogenic arteriopathy" (PPA) in children Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010 Systemic vascularization in intralobar pulmonary sequestration - congenital or acquired? Source: Eur Respir J 2001; 18: Suppl. 33, 492s Year: 2001 Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Source: Eur Respir J 2002; 19: 976-979 Year: 2002 Arterial bilateral embolisation in evolutive tuberculosis: one case report Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005 Pulmonary arterial hypertension associated with exposure to fenfluramine: a report of 109 cases Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns Source: Eur Respir J, 53 (3) 1900135; 10.1183/13993003.00135-2019 Year: 2019 Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Pulmonary vascular resistances during exercise in normal subjects: a systematic review Source: Eur Respir J 2012; 39: 319-328 Year: 2012